Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus salivarius UCC118 and Reduced Inflammation

Research synthesisModerate evidenceModerate effect8 studies · 8 beneficial · 0 neutral · 0 harmful

All 8 studies reported beneficial effects of Lactobacillus salivarius UCC118 on reducing inflammation, with a predominant moderate effect size. Three studies were statistically significant. The strongest evidence comes from a meta-analysis in women with gestational diabetes mellitus (small effect) and an RCT in patients with multiple sclerosis (moderate effect). Doses were not consistently reported across studies.

  • Studied populations: women with gestational diabetes mellitus, patients with relapsing-remitting multiple sclerosis

Caveats: Many studies are reviews that do not isolate the specific strain L. salivarius UCC118; results may reflect broader probiotic effects. Doses were not reported, limiting dose-response conclusions. The meta-analysis reported a small effect size, indicating modest clinical impact. Further research with standardized strains and doses is needed.

Generated May 10, 2026
8 of 8 papers
Back to top